Post-Myocardial Infarction Guideline-Recommended Therapy Utilizing Sankey Diagrams Among Medicare Beneficiaries
Authors:
- 26 November 2025
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiopulmonary Rehabilitation and Prevention
- Vol. 46 (2) , 107-114
Abstract
Purpose: To describe 2-year post-myocardial infarction (MI) longitudinal patterns of guideline- directed medical therapy (GDMT) and cardiac rehabilitation (CR) participation with Sankey diagrams. Methods: Eligible Medicare beneficiaries were aged 66 to 95 years with an acute MI (International Classification of Diseases-9-CM discharge codes of 410.xx excluding 410.x2) hospital admission between January 1, 2014 and September 30, 2015 and ≥1 follow-up CR sessions. We defined GDMT (angiotensin converting enzyme-inhibitor or angiotensin receptor blocker, statin, and β-blocker) use as having at least a 21-day supply available during a 30-day window. We stratified CR participation by days with claims (1-11, 12-23, ≥ 24). Population level trends of 6 GDMT combinations, CR participation, and death were depicted with Sankey diagrams. Results: Study population consisted of 5793 beneficiaries, 72% of whom had ≥1 GDMT pre-MI, 93% had ≥1 GDMT at baseline, and 45% initiated CR by 30 days post-MI. A median 23% of CR participants did not flow from low to moderate CR participation each month. At 1-year post-MI, 37% of beneficiaries without pre-MI GDMT and 33% of beneficiaries with pre-MI GDMT concluded CR early. Between 9% and 16% of beneficiaries without pre-MI GDMT and 2% to 6% beneficiaries with pre-MI GDMT did not have a GDMT fill post-MI. On average, 4% to 5% of beneficiaries switched from β-blocker + statin to another GDMT group post-MI each month. Conclusions: Describing patterns of secondary prevention method utilization with Sankey diagrams can identify intervention populations, such as groups with inconsistent CR participation, primary nonadherence to new medications, and volatile medication persistence.Keywords
This publication has 32 references indexed in Scilit:
- Persistence of overactive bladder pharmacological treatment in women as reflected from large‐scale real‐world data of prescription claims: A retrospective cohort studyNeurourology and Urodynamics, 2023
- Cardiac Rehabilitation Reduces 2-Year Mortality After Coronary Artery Bypass GraftingThe Annals of Thoracic Surgery, 2023
- Assessment of Depression and Adherence to Guideline-Directed Medical Therapies Following Percutaneous Coronary InterventionJAMA Network Open, 2022
- Drug Adherence and Long-Term Outcomes in Non-Revascularized Patients Following Acute Myocardial InfarctionThe American Journal of Cardiology, 2021
- Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial InfarctionJACC, 2017
- Effectiveness of cardiac rehabilitation among older patients after acute myocardial infarctionAmerican Heart Journal, 2015
- Adherence to evidence-based secondary prevention pharmacotherapy in patients after an acute coronary syndrome: A systematic reviewHeart & Lung, 2015
- Association between trajectories of statin adherence and subsequent cardiovascular eventsPharmacoepidemiology and Drug Safety, 2015
- Using claims data to predict dependency in activities of daily living as a proxy for frailtyPharmacoepidemiology and Drug Safety, 2014
- Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims dataEuropean Journal of Clinical Pharmacology, 2012